Good evening and welcome to Markets Desk, your close of day read on what's moving markets and the broader economy.
Microsoft CEO Satya Nadella made waves today with a striking posture on artificial intelligence governance, telling audiences that companies should treat their own AI models as insider threats — essentially compromised from the start — and calling for a human-controlled emergency brake on frontier development. It's a remarkable statement from the man running one of the world's largest AI bets, and it signals that the governance conversation is no longer theoretical.
Staying with the consumer economy, Crumbl Cookies is closing locations, and the story behind those closures cuts deeper than a single brand stumbling. Analysts point to a double pressure: elevated prices on discretionary indulgences at a moment when consumer confidence is fragile, compounded by the rapid adoption of GLP-one appetite-suppressing drugs among millions of Americans. That combination is a structural headwind, not a temporary one.
And in the pharmaceutical space, patients paying as much as one thousand five hundred dollars a month for compounded peptide therapies are running into a hard regulatory wall. The FDA's evolving posture on compounded drugs means cash-pay patients face not just cost risk but availability risk — a distinction that carries real consequences for household budgets already under strain.
That's the tape. Markets Desk, signing off the floor.
